Brain Immune Interactions In Type 2 Diabetes
2 型糖尿病中的脑免疫相互作用
基本信息
- 批准号:8452102
- 负责人:
- 金额:$ 32.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-03-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AmericanAnti-Inflammatory AgentsAnti-inflammatoryAreaBehaviorBrainDataDesire for foodDevelopmentDiabetes MellitusDiabetic mouseDietDietary InterventionDiseaseEquilibriumFailureGoalsImmuneInflammationInterleukin-1Interleukin-12Interleukin-4Knockout MiceLaboratoriesLinkLipopolysaccharidesMediatingMemory LossMusNatural ImmunityNon-Insulin-Dependent Diabetes MellitusPathway interactionsPhenotypePrevalenceProductionProteinsRecoveryRegulationReportingResearchResearch Project GrantsResistanceSeveritiesSpleenSymptomsSystemTransplantationUp-RegulationWild Type MouseWithdrawalWorkarginaseattenuationbasebiobehaviorbrain behaviorcytokinediabeticfeedinggastrointestinalimprovedinnovationinsightmacrophagemannose receptormouse modelpreventpublic health relevancereceptorresearch studysocialsoluble fiber
项目摘要
DESCRIPTION (provided by applicant): The prevalence of type 2 diabetes (T2D) has risen dramatically in the last 20 years with the American Diabetes Association now reporting that 20.8 million Americans suffer from this disease. As we have shown and reviewed, inflammation, especially IL-12/IL-1RA balance, is vital to the development and persistence of biobehavioral complications in T2D. We have demonstrated that increased severity and delayed recovery from neuroimmune activation in mouse models of diabetes is due to a failure in IL-12 counter-regulation and can be rectified by IL-1 receptor antagonist (IL-1RA) administration. Critically, we have shown that diabetic mice are in a "state of IL-4 resistance" and that IL-4 is key to lipopolysaccharide (LPS)-dependent up-regulation of IL- 1RA.Therefore, the objective of this research project is to examine the hypothesis that activation of the neuroimmune system in T2D is exacerbated by attenuation of crucial cytokine-based counter-regulatory anti-inflammatory pathways. The long-term goal of this project is to develop strategies to abrogate and/or ameliorate the development of the diabetic proinflammatory state and prevent its adverse impact on the brain and behavior. In support of these aims, exciting new preliminary data from our laboratory reveal the importance of IL-4 to biobehavioral recovery from LPS because IL-4 knockout (KO) mice have significantly increased LPS-induced sickness and slower recovery when compared to wild type mice. In addition, we have discovered an innovative way to induce IL-4 expression in mice that, also, augments macrophage alternative activation. We have discovered that feeding mice a diet enriched in soluble fiber causes marked up-regulation of IL-4 in the brain, spleen and gastrointestinal (GI), boosts macrophage production of IL-1RA and affords mice dramatic resistance to LPS-induced social withdrawal. Importantly, IL-4 KO mice do not gain the benefit of this diet. Altogether, these findings are the first to show the potential consequence of IL-4 to sickness and sickness recovery. They also provide insight into how IL-4 would modulate neuroimmunity and sickness-associated behaviors. In Objective #1, we will determine what sickness symptoms are controlled by IL-4. In Objective #2, we will ascertain if IL-4-dependent recovery from sickness is reliant on the ability of IL-4 to drive the macrophage alternative activation phenotype and if it is mediated by IL-4-dependent regulation of IL-1/IL-1RA balance. In Objective #3, we will discern whether soluble fiber can be used to block sickness and/or improve sickness recovery and establish if it will work in mouse models of T2D. These studies are needed to identify new targets for the alleviation of suffering in those afflicted by T2D.
描述(由申请人提供):2型糖尿病(T2D)的患病率在过去20年里急剧上升,美国糖尿病协会现在报告称,有2080万美国人患有这种疾病。正如我们已经展示和回顾的,炎症,特别是IL-12/IL-1RA平衡,对T2D生物行为并发症的发生和持续至关重要。我们已经证明,糖尿病小鼠模型的严重程度增加和从神经免疫激活中恢复的延迟是由于IL-12反向调节失败,可以通过给予IL-1受体拮抗剂(IL-1RA)来纠正。重要的是,我们已经证明糖尿病小鼠处于“IL-4抵抗状态”,并且IL-4是依赖脂多糖(LPS)上调IL-1RA的关键。因此,本研究项目的目的是验证一种假说,即T2D中神经免疫系统的激活是由于关键的基于细胞因子的反调节抗炎通路的减弱而加剧的。该项目的长期目标是制定策略,以消除和/或改善糖尿病前炎症状态的发展,并防止其对大脑和行为的不利影响。为了支持这些目标,来自我们实验室的令人兴奋的新的初步数据揭示了IL-4对从内毒素中恢复生物行为的重要性,因为与野生型小鼠相比,IL-4基因敲除(KO)小鼠显著增加了内毒素诱导的疾病并且恢复得更慢。此外,我们还发现了一种诱导小鼠IL-4表达的创新方法,这种方法还可以增强巨噬细胞的选择性激活。我们发现,给小鼠喂食富含可溶性纤维的食物会导致脑、脾和胃肠道(GI)中IL-4的显著上调,促进巨噬细胞产生IL-1RA,并使小鼠对内毒素诱导的社交退缩产生戏剧性的抵抗。重要的是,IL-4KO小鼠不会从这种饮食中受益。总之,这些发现首次显示了IL-4对疾病和疾病康复的潜在后果。他们还提供了对IL-4如何调节神经免疫和疾病相关行为的洞察。在目标1中,我们将确定IL-4控制哪些疾病症状。在目标2中,我们将确定IL-4依赖的疾病康复是否依赖于IL-4驱动巨噬细胞选择性激活表型的能力,以及它是否通过IL-4依赖的对IL-1/IL-1RA平衡的调节来介导。在目标3中,我们将辨别可溶性纤维是否可以用来阻止疾病和/或改善疾病恢复,并确定它是否适用于T2D小鼠模型。需要这些研究来确定减轻T2D患者痛苦的新目标。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
IL-1 receptor 2 (IL-1R2) and its role in immune regulation.
- DOI:10.1016/j.bbi.2012.11.006
- 发表时间:2013-08
- 期刊:
- 影响因子:15.1
- 作者:Peters, Vanessa A.;Joesting, Jennifer J.;Freund, Gregory G.
- 通讯作者:Freund, Gregory G.
Accelerated recovery from acute hypoxia in obese mice is due to obesity-associated up-regulation of interleukin-1 receptor antagonist.
肥胖小鼠从急性缺氧中加速恢复是由于肥胖相关的白介素 1 受体拮抗剂的上调。
- DOI:10.1210/en.2008-1622
- 发表时间:2009
- 期刊:
- 影响因子:4.8
- 作者:Sherry,ChristinaL;Kim,StephanieS;Freund,GregoryG
- 通讯作者:Freund,GregoryG
Short-Term High-Fat Diet (HFD) Induced Anxiety-Like Behaviors and Cognitive Impairment Are Improved with Treatment by Glyburide.
- DOI:10.3389/fnbeh.2016.00156
- 发表时间:2016
- 期刊:
- 影响因子:3
- 作者:Gainey SJ;Kwakwa KA;Bray JK;Pillote MM;Tir VL;Towers AE;Freund GG
- 通讯作者:Freund GG
Individually ventilated cages cause chronic low-grade hypoxia impacting mice hematologically and behaviorally.
单独通风的笼子会导致慢性低度缺氧,影响小鼠的血液学和行为。
- DOI:10.1016/j.bbi.2012.04.008
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:York,JasonM;McDaniel,AllisonW;Blevins,NeilA;Guillet,RileyR;Allison,SarahO;Cengel,KeithA;Freund,GregoryG
- 通讯作者:Freund,GregoryG
Mouse testing methods in psychoneuroimmunology: an overview of how to measure sickness, depressive/anxietal, cognitive, and physical activity behaviors.
- DOI:10.1007/978-1-62703-071-7_13
- 发表时间:2012-11
- 期刊:
- 影响因子:0
- 作者:J. York;N. A. Blevins;T. Baynard;G. Freund
- 通讯作者:J. York;N. A. Blevins;T. Baynard;G. Freund
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory G Freund其他文献
Additional collection devices used in conjunction with the SurePath Liquid-Based Pap Test broom device do not enhance diagnostic utility
- DOI:
10.1186/1472-6874-4-6 - 发表时间:
2004-09-13 - 期刊:
- 影响因子:2.700
- 作者:
Sarah J Day;Darla L O'Shaughnessy;Jason C O'Connor;Gregory G Freund - 通讯作者:
Gregory G Freund
Gregory G Freund的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory G Freund', 18)}}的其他基金
Changing behavior by shifting Th1/Th2 balance in the brain
通过改变大脑中 Th1/Th2 平衡来改变行为
- 批准号:
7937101 - 财政年份:2009
- 资助金额:
$ 32.61万 - 项目类别:
Changing behavior by shifting Th1/Th2 balance in the brain
通过改变大脑中 Th1/Th2 平衡来改变行为
- 批准号:
7818664 - 财政年份:2009
- 资助金额:
$ 32.61万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 32.61万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 32.61万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 32.61万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 32.61万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 32.61万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 32.61万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 32.61万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 32.61万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 32.61万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 32.61万 - 项目类别: